reaction_smiles,sources,reactants,products,solvents,catalyst,stages
"['C([Li])CCC.[C:6]([O:10][C:11]([NH:13][C:14]1[CH:19]=[CH:18][N:17]=[CH:16][CH:15]=1)=[O:12])([CH3:9])([CH3:8])[CH3:7].CCOCC.[C:25](=[O:27])=[O:26]', 'C1COCC1.C(O)(=O)C.O', '[C:6]([O:10][C:11]([NH:13][C:14]1[C:15]([C:25]([OH:27])=[O:26])=[CH:16][N:17]=[CH:18][CH:19]=1)=[O:12])([CH3:9])([CH3:7])[CH3:8]']","['US20010027197A1', '0324', 'n-Butyl lithium (2.18 M, 24 mL, 52.51 mmol) is added slowly to a solution of 4-(N-t-butoxycarbonylamino)pyridine (4.08 g, 21 mmol) in THF (50 mL, stirred under N2 at −78° C. The solution is allowed to warm to 0° C., stirred for 3 h, then cooled again to −78° C. and poured into ether (100 mL) containing dry ice. The solution is warmed to room temperature with constant stirring. Water is added and the mixture is neutralized with acetic acid. The resulting solid is collected by vacuum filtration and dried in a vacuum oven to give 4-(N-t-butoxycarbonylamino)nicotinic acid (2.72 g, 54%) as a brown solid. 1H NMR (DMSO) δ 11.75 (1H, brs), 8.95 (1H, s), 8.50 (1H, d, J=6.0 Hz), 8.20 (1H, d, J=6.0 Hz), 1.49 (9H, s).']","[{'chemical_names': ['n-Butyl lithium'], 'identifiers': ['smiles:[Li]CCCC', 'inchi:InChI=1S/C4H9.Li/c1-3-4-2;/h1,3-4H2,2H3;'], 'amounts': ['52.51 mmol', '2.18 M', '24 mL'], 'appearances': []}, {'chemical_names': ['4-(N-t-butoxycarbonylamino)pyridine'], 'identifiers': ['smiles:CC(C)(C)OC(=O)Nc1ccncc1', 'inchi:InChI=1S/C10H14N2O2/c1-10(2,3)14-9(13)12-8-4-6-11-7-5-8/h4-7H,1-3H3,(H,11,12,13)'], 'amounts': ['21 mmol', '4.08 g'], 'appearances': []}, {'chemical_names': ['ether'], 'identifiers': ['smiles:CCOCC', 'inchi:InChI=1S/C4H10O/c1-3-5-4-2/h3-4H2,1-2H3'], 'amounts': ['100 mL'], 'appearances': []}, {'chemical_names': ['dry ice'], 'identifiers': ['smiles:O=C=O', 'inchi:InChI=1S/CO2/c2-1-3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['4-(N-t-butoxycarbonylamino)nicotinic acid'], 'identifiers': ['smiles:CC(C)(C)OC(=O)Nc1ccncc1C(=O)O', 'inchi:InChI=1S/C11H14N2O4/c1-11(2,3)17-10(16)13-8-4-5-12-6-7(8)9(14)15/h4-6H,1-3H3,(H,14,15)(H,12,13,16)'], 'amounts': ['2.72 g', '54%'], 'appearances': ['brown']}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['Water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:n-Butyl lithium (2.18 M, 24 mL, 52.51 mmol) is added slowly to a solution of 4-(N-t-butoxycarbonylamino)pyridine (4.08 g, 21 mmol) in THF (50 mL', 'step 2:stirred under N2 at −78° C', 'step 2 properties:Temperature:-78', 'step 3:to warm to 0° C.', 'step 3 properties:Temperature:0', 'step 4:stirred for 3 h', 'step 4 properties:Time:10800', 'step 5:cooled again to −78° C.', 'step 5 properties:Temperature:-78', 'step 6:poured into ether (100 mL)', 'step 7:containing dry ice', 'step 8:The solution is warmed to room temperature with constant stirring', 'step 8 properties:Temperature:room temperature', 'step 9:Water is added', 'step 10:The resulting solid is collected by vacuum filtration', 'step 11:dried in a vacuum oven', 'step 12:to give 4-(N-t-butoxycarbonylamino)nicotinic acid (2.72 g, 54%) as a brown solid']"
"['[CH:1]([NH:3][C:4]1[CH:9]=[C:8]([N+:10]([O-:12])=[O:11])[CH:7]=[CH:6][C:5]=1[O:13][CH3:14])=O.[BH4-].[Na+].C(O)(=O)C', 'O1CCOCC1', '[CH3:1][NH:3][C:4]1[CH:9]=[C:8]([N+:10]([O-:12])=[O:11])[CH:7]=[CH:6][C:5]=1[O:13][CH3:14] |f:1.2|']","['US20010027211A1', '0094', 'To a 0.5M solution of 2-formamido-4-nitroanisole (745 mg, 3.8 mmol) in dioxane was added sodium borohydride (722 mg, 19 mmol) followed by dropwise addition of glacial acetic acid (1.09 mL, 19 mmol). The reaction mixture was refluxed for 40 minutes, then cooled to 0° C. and quenched slowly with MeOH. Excess MeOH was then added and the solution was concentrated under vacuum to yield 2-methylamino-4-nitroanisole. The crude product was dissolved in anhydrous MeOH (20 mL) and Pd/C (795 mg, 0.76 mmol) was added followed by bubbling hydrogen gas through the solution for 1 minute. The reaction mixture was then stirred for 1.5 h under 1 atmosphere of hydrogen. The reaction mixture was filtered through a pad of Celite and the filter pad was washed with MeOH (40 mL). To the combined filtrate and wash was added pentafluorophenylsulfonyl chloride (282 mL, 0.26 mmol). After stirring for 30 min the reaction mixture was concentrated under vacuum and purified by column chromatography (10-25% EtOAc in hexane) to yield 153 mg (21% for three steps) of the title compound as a pale yellow solid. 1H NMR (400MHz, DMSO-d6) δ10.7 (s, 1H), 6.68 (d, J=8.4 Hz, 1H), 6.3 (dd, J=8.3, 2.5 Hz, 1H), 6.22 (d, J=2.2 Hz, 1H), 5.18 (bs, 1H), 3.7 (s, 3H), 2.6 (d, J=3 Hz, 3H). MS(EI): m/z 785 (35, 2M+Na−2H), 382 (20, M+), 381 (100, M−H).']","[{'chemical_names': ['solution'], 'identifiers': [], 'amounts': ['0.5M'], 'appearances': []}, {'chemical_names': ['2-formamido-4-nitroanisole'], 'identifiers': ['smiles:COc1ccc([N+](=O)[O-])cc1NC=O', 'inchi:InChI=1S/C8H8N2O4/c1-14-8-3-2-6(10(12)13)4-7(8)9-5-11/h2-5H,1H3,(H,9,11)'], 'amounts': ['3.8 mmol', '745 mg'], 'appearances': []}, {'chemical_names': ['sodium borohydride'], 'identifiers': ['smiles:[BH4-].[Na+]', 'inchi:InChI=1S/BH4.Na/h1H4;/q-1;+1'], 'amounts': ['19 mmol', '722 mg'], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['19 mmol', '1.09 mL'], 'appearances': []}]","[{'chemical_names': ['2-methylamino-4-nitroanisole'], 'identifiers': ['smiles:CNc1cc([N+](=O)[O-])ccc1OC', 'inchi:InChI=1S/C8H10N2O3/c1-9-7-5-6(10(11)12)3-4-8(7)13-2/h3-5,9H,1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['dioxane'], 'identifiers': ['smiles:C1COCCO1', 'inchi:InChI=1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:To a 0.5M solution of 2-formamido-4-nitroanisole (745 mg, 3.8 mmol) in dioxane was added sodium borohydride (722 mg, 19 mmol)', 'step 2:followed by dropwise addition of glacial acetic acid (1.09 mL, 19 mmol)', 'step 3:The reaction mixture was refluxed for 40 minutes', 'step 3 properties:Time:2400', 'step 4:cooled to 0° C.', 'step 4 properties:Temperature:0', 'step 5:quenched slowly with MeOH', 'step 6:Excess MeOH was then added', 'step 7:the solution was concentrated under vacuum', 'step 8:to yield 2-methylamino-4-nitroanisole']"
"['[NH2:1][C:2]1[N:7]=[C:6]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[CH:5]=[CH:4][N:3]=1.[I:14]N1C(=O)CCC1=O', 'C(O)(=O)C', '[I:14][C:5]1[C:6]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)=[N:7][C:2]([NH2:1])=[N:3][CH:4]=1']","['US20010027196A1', '0619', 'To a stirred solution of 500 mg (2.9 mmol) 2-amino-4-phenylpyrimidine in 38 ml acetic acid was added 689 mg (3.1 mmol) N-iodosuccinimide and stirring continued in the dark at room temperature for 16 h. The reaction mixture was then concentrated in vacuo and the residue partitioned between ether and water. The organic phase was then dried over sodium sulfate and concentrated in vacuo. Trituration in ether/ethyl acetate then afforded 138 mg (16%) 5-iodo-4-phenyl-pyrimidin-2-ylamine as a yellow crystalline solid. EI-MS m/e (%): 297 (M+, 100), 170 ([M—I]+, 38).']","[{'chemical_names': ['2-amino-4-phenylpyrimidine'], 'identifiers': ['smiles:Nc1nccc(-c2ccccc2)n1', 'inchi:InChI=1S/C10H9N3/c11-10-12-7-6-9(13-10)8-4-2-1-3-5-8/h1-7H,(H2,11,12,13)'], 'amounts': ['2.9 mmol', '500 mg'], 'appearances': []}, {'chemical_names': ['N-iodosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1I', 'inchi:InChI=1S/C4H4INO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': ['3.1 mmol', '689 mg'], 'appearances': []}]","[{'chemical_names': ['5-iodo-4-phenyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:Nc1ncc(I)c(-c2ccccc2)n1', 'inchi:InChI=1S/C10H8IN3/c11-8-6-13-10(12)14-9(8)7-4-2-1-3-5-7/h1-6H,(H2,12,13,14)'], 'amounts': ['138 mg', '16%', '16.0'], 'appearances': ['yellow crystalline']}]","[{'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['38 ml'], 'appearances': []}]",[],"['step 1:To a stirred solution of 500 mg (2.9 mmol) 2-amino-4-phenylpyrimidine in 38 ml acetic acid was added 689 mg (3.1 mmol) N-iodosuccinimide', 'step 2:stirring', 'step 3:dark at room temperature', 'step 3 properties:Temperature:room temperature', 'step 4:for 16 h', 'step 4 properties:Time:57600', 'step 5:The reaction mixture was then concentrated in vacuo', 'step 6:the residue partitioned between ether and water', 'step 7:The organic phase was then dried over sodium sulfate', 'step 8:concentrated in vacuo', 'step 9:Trituration in ether/ethyl acetate then afforded 138 mg (16%) 5-iodo-4-phenyl-pyrimidin-2-ylamine as a yellow crystalline solid']"
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[CH:11]=[C:10]([S:12][CH3:13])[N:9]=[C:8]([NH2:14])[N:7]=1.[Br:15]N1C(=O)CCC1=O', 'C(O)(=O)C', '[Br:15][C:11]1[C:6]([C:2]2[O:1][CH:5]=[CH:4][CH:3]=2)=[N:7][C:8]([NH2:14])=[N:9][C:10]=1[S:12][CH3:13]']","['US20010027196A1', '0964', 'To a stirred solution of 197 mg (0.95 mmol) 4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine in 15 ml acetic acid was added 178 mg (1.00 mmol) N-bromosuccinimide and stirring continued at room temperature for 48 h. The reaction mixture was then concentrated in vacuo and the residue partitioned between ether and water. The organic phase was dried over, sodium sulfate and concentrated in vacuo. Chromatography (ethyl acetate/hexane 1/2) followed by trituration in ether/hexane then afforded 93 mg (34%) 5-bromo-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine as a yellow crystalline solid. EI-MS m/e (%): 287 (M{81Br}+, 44), 285 (M{79Br}+, 42), 206 ([M—Br]+, 100).']","[{'chemical_names': ['4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1cc(-c2ccco2)nc(N)n1', 'inchi:InChI=1S/C9H9N3OS/c1-14-8-5-6(11-9(10)12-8)7-3-2-4-13-7/h2-5H,1H3,(H2,10,11,12)'], 'amounts': ['0.95 mmol', '197 mg'], 'appearances': []}, {'chemical_names': ['N-bromosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1Br', 'inchi:InChI=1S/C4H4BrNO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': ['1.00 mmol', '178 mg'], 'appearances': []}]","[{'chemical_names': ['5-bromo-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccco2)c1Br', 'inchi:InChI=1S/C9H8BrN3OS/c1-15-8-6(10)7(12-9(11)13-8)5-3-2-4-14-5/h2-4H,1H3,(H2,11,12,13)'], 'amounts': ['93 mg', '34%', '34.2'], 'appearances': ['yellow crystalline']}]","[{'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['15 ml'], 'appearances': []}]",[],"['step 1:To a stirred solution of 197 mg (0.95 mmol) 4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine in 15 ml acetic acid was added 178 mg (1.00 mmol) N-bromosuccinimide', 'step 2:stirring', 'step 3:continued at room temperature for 48 h', 'step 3 properties:Time:172800', 'step 3 properties:Temperature:room temperature', 'step 4:The reaction mixture was then concentrated in vacuo', 'step 5:the residue partitioned between ether and water', 'step 6:The organic phase was dried over, sodium sulfate', 'step 7:concentrated in vacuo', 'step 8:then afforded 93 mg (34%) 5-bromo-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine as a yellow crystalline solid']"
"['[C:1]([C:4]1O[CH:6]=[CH:7][CH:8]=1)(=O)[CH3:2].COC(OC)N(C)C.[C:17](=[O:20])(O)O.[NH2:21][C:22]([NH2:24])=[NH:23].C[O-].[Na+].[I:28]N1C(=O)CCC1=O', 'CN(C=O)C.CO.C(O)(=O)C', '[O:20]1[CH:17]=[CH:6][CH:7]=[C:8]1[C:4]1[C:1]([I:28])=[CH:2][N:21]=[C:22]([NH2:24])[N:23]=1 |f:2.3,4.5|']","['US20010027196A1', '4-Furan-2-yl-5-iodo-pyrimidin-2-ylamine', '0967', 'From 2-acetylfuran and N,N-dimethylformamide dimethyl acetal in DMF. Then treatment with guanidine carbonate and sodium methylate in methanol. Then treatment with N-iodosuccinimide in acetic acid. EI-MS m/e (%): 287 (M+, 100).']","[{'chemical_names': ['2-acetylfuran'], 'identifiers': ['smiles:CC(=O)c1ccco1', 'inchi:InChI=1S/C6H6O2/c1-5(7)6-3-2-4-8-6/h2-4H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N,N-dimethylformamide dimethyl acetal'], 'identifiers': ['smiles:COC(OC)N(C)C', 'inchi:InChI=1S/C5H13NO2/c1-6(2)5(7-3)8-4/h5H,1-4H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine carbonate'], 'identifiers': ['smiles:N=C(N)N.O=C(O)O', 'inchi:InChI=1S/CH5N3.CH2O3/c2*2-1(3)4/h(H5,2,3,4);(H2,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium methylate'], 'identifiers': ['smiles:C[O-].[Na+]', 'inchi:InChI=1S/CH3O.Na/c1-2;/h1H3;/q-1;+1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N-iodosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1I', 'inchi:InChI=1S/C4H4INO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['4-Furan-2-yl-5-iodo-pyrimidin-2-ylamine'], 'identifiers': ['smiles:Nc1ncc(I)c(-c2ccco2)n1', 'inchi:InChI=1S/C8H6IN3O/c9-5-4-11-8(10)12-7(5)6-2-1-3-13-6/h1-4H,(H2,10,11,12)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methanol'], 'identifiers': ['smiles:CO', 'inchi:InChI=1S/CH4O/c1-2/h2H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[CH:11]=[C:10]([S:12][CH3:13])[N:9]=[C:8]([NH2:14])[N:7]=1.[I:15]N1C(=O)CCC1=O', 'C(O)(=O)C', '[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[C:11]([I:15])=[C:10]([S:12][CH3:13])[N:9]=[C:8]([NH2:14])[N:7]=1']","['US20010027196A1', '4-Furan-2-yl-5-iodo-6-methylsulfanyl-pyrimidin-2-ylamine', '0970', 'From 4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine and N-iodosuccinimide in acetic acid. EI-MS m/e (%): 333 (M+, 66), 206 ([M—I]+, 100), 118 (44).']","[{'chemical_names': ['4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1cc(-c2ccco2)nc(N)n1', 'inchi:InChI=1S/C9H9N3OS/c1-14-8-5-6(11-9(10)12-8)7-3-2-4-13-7/h2-5H,1H3,(H2,10,11,12)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N-iodosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1I', 'inchi:InChI=1S/C4H4INO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['( 44 )'], 'identifiers': [], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['4-Furan-2-yl-5-iodo-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccco2)c1I', 'inchi:InChI=1S/C9H8IN3OS/c1-15-8-6(10)7(12-9(11)13-8)5-3-2-4-14-5/h2-4H,1H3,(H2,11,12,13)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}]",[],[]
"['[C:1]([C:4]1O[CH:6]=[CH:7][CH:8]=1)(=O)[CH3:2].COC(OC)N(C)C.[C:17](=[O:20])(O)O.[NH2:21][C:22]([NH2:24])=[NH:23].C[O-].[Na+].[Br:28]N1C(=O)CCC1=O', 'CN(C=O)C.CO.C(O)(=O)C', '[Br:28][C:1]1[C:4]([C:8]2[O:20][CH:17]=[CH:6][CH:7]=2)=[N:23][C:22]([NH2:24])=[N:21][CH:2]=1 |f:2.3,4.5|']","['US20010027196A1', '5-Bromo-4-furan-2-yl-pyrimidin-2-ylamine', '0990', 'From 2-acetylfuran and N,N-dimethylformamide dimethyl acetal in DMF. Then treatment with guanidine carbonate and sodium methylate in methanol. Then treatment with N-bromosuccinimide in acetic acid. EI-MS m/e (%): 241 (M{81Br}+, 98), 239 (M{81Br}+, 100).']","[{'chemical_names': ['2-acetylfuran'], 'identifiers': ['smiles:CC(=O)c1ccco1', 'inchi:InChI=1S/C6H6O2/c1-5(7)6-3-2-4-8-6/h2-4H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N,N-dimethylformamide dimethyl acetal'], 'identifiers': ['smiles:COC(OC)N(C)C', 'inchi:InChI=1S/C5H13NO2/c1-6(2)5(7-3)8-4/h5H,1-4H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine carbonate'], 'identifiers': ['smiles:N=C(N)N.O=C(O)O', 'inchi:InChI=1S/CH5N3.CH2O3/c2*2-1(3)4/h(H5,2,3,4);(H2,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium methylate'], 'identifiers': ['smiles:C[O-].[Na+]', 'inchi:InChI=1S/CH3O.Na/c1-2;/h1H3;/q-1;+1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N-bromosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1Br', 'inchi:InChI=1S/C4H4BrNO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['5-Bromo-4-furan-2-yl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:Nc1ncc(Br)c(-c2ccco2)n1', 'inchi:InChI=1S/C8H6BrN3O/c9-5-4-11-8(10)12-7(5)6-2-1-3-13-6/h1-4H,(H2,10,11,12)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methanol'], 'identifiers': ['smiles:CO', 'inchi:InChI=1S/CH4O/c1-2/h2H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}]",[],[]
"['[C:1]([C:4]1O[CH:6]=[CH:7][CH:8]=1)(=O)[CH3:2].COC(OC)N(C)C.[C:17](=[O:20])(O)O.[NH2:21][C:22]([NH2:24])=[NH:23].C[O-].[Na+].[Cl:28]N1C(=O)CCC1=O', 'CN(C=O)C.CO.C(O)(=O)C', '[Cl:28][C:1]1[C:4]([C:8]2[O:20][CH:17]=[CH:6][CH:7]=2)=[N:23][C:22]([NH2:24])=[N:21][CH:2]=1 |f:2.3,4.5|']","['US20010027196A1', '5-Chloro-4-furan-2-yl-pyrimidin-2-ylamine', '1019', 'From 2-acetylfuran and N,N-dimethylformamide dimethyl acetal in DMF. Then treatment with guanidine carbonate and sodium methylate in methanol. Then treatment with N-chlorosuccinimide in acetic acid. EI-MS m/e (%): 197 (M{37Cl}+, 32), 195 (M{35Cl}+, 100).']","[{'chemical_names': ['2-acetylfuran'], 'identifiers': ['smiles:CC(=O)c1ccco1', 'inchi:InChI=1S/C6H6O2/c1-5(7)6-3-2-4-8-6/h2-4H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N,N-dimethylformamide dimethyl acetal'], 'identifiers': ['smiles:COC(OC)N(C)C', 'inchi:InChI=1S/C5H13NO2/c1-6(2)5(7-3)8-4/h5H,1-4H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['guanidine carbonate'], 'identifiers': ['smiles:N=C(N)N.O=C(O)O', 'inchi:InChI=1S/CH5N3.CH2O3/c2*2-1(3)4/h(H5,2,3,4);(H2,2,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['sodium methylate'], 'identifiers': ['smiles:C[O-].[Na+]', 'inchi:InChI=1S/CH3O.Na/c1-2;/h1H3;/q-1;+1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N-chlorosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1Cl', 'inchi:InChI=1S/C4H4ClNO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['5-Chloro-4-furan-2-yl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:Nc1ncc(Cl)c(-c2ccco2)n1', 'inchi:InChI=1S/C8H6ClN3O/c9-5-4-11-8(10)12-7(5)6-2-1-3-13-6/h1-4H,(H2,10,11,12)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['DMF'], 'identifiers': ['smiles:CN(C)C=O', 'inchi:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['methanol'], 'identifiers': ['smiles:CO', 'inchi:InChI=1S/CH4O/c1-2/h2H,1H3'], 'amounts': [], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}]",[],[]
"['[O:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[CH:11]=[C:10]([S:12][CH3:13])[N:9]=[C:8]([NH2:14])[N:7]=1.[Cl:15]N1C(=O)CCC1=O', 'C(O)(=O)C', '[Cl:15][C:11]1[C:6]([C:2]2[O:1][CH:5]=[CH:4][CH:3]=2)=[N:7][C:8]([NH2:14])=[N:9][C:10]=1[S:12][CH3:13]']","['US20010027196A1', '5-Chloro-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine', '1027', 'From 4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine and N-chlorosuccinimide in acetic acid. ES-MS m/e (%): 244 (M{37Cl}+H+, 40), 242 (M{35Cl}+H+, 100).']","[{'chemical_names': ['4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1cc(-c2ccco2)nc(N)n1', 'inchi:InChI=1S/C9H9N3OS/c1-14-8-5-6(11-9(10)12-8)7-3-2-4-13-7/h2-5H,1H3,(H2,10,11,12)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['N-chlorosuccinimide'], 'identifiers': ['smiles:O=C1CCC(=O)N1Cl', 'inchi:InChI=1S/C4H4ClNO2/c5-6-3(7)1-2-4(6)8/h1-2H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['M{37Cl} H+'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['M{35Cl} H+'], 'identifiers': [], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['5-Chloro-4-furan-2-yl-6-methylsulfanyl-pyrimidin-2-ylamine'], 'identifiers': ['smiles:CSc1nc(N)nc(-c2ccco2)c1Cl', 'inchi:InChI=1S/C9H8ClN3OS/c1-15-8-6(10)7(12-9(11)13-8)5-3-2-4-14-5/h2-4H,1H3,(H2,11,12,13)'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}]",[],[]
"['[Na].[C:2]([C:4]([C:11]#[N:12])=[C:5]([NH:8][C:9]#[N:10])[S:6][CH3:7])#[N:3].[BrH:13]', 'C(O)(=O)C', '[NH2:10][C:9]1[N:3]=[C:2]([Br:13])[C:4]([C:11]#[N:12])=[C:5]([S:6][CH3:7])[N:8]=1 |f:0.1,^1:0|']","['US20010027196A1', '1707', 'To a stirred suspension of 1.00 g (5.37 mmol) 2,2-dicyano-1-methylsulfanyl-vinyl-cyanamide sodium salt in 10 ml acetic acid at 5° C. was added dropwise 10 ml hydrobromic acid solution (33% in acetic acid) and the mixture was stirred at room temperature for 30 minutes. The mixture was then poured onto 100 ml ice-water added. The resulting crystals were collected by filtration and washed with water (ca 500 ml) until the washings were free of bromide ion. Chromatography (ethyl acetate/hexane 1/4) afforded 1.09 g (83%) 2-amino-4-bromo-6-methylsulfanyl-pyrimidine-5-carbonitrile as a white crystalline solid. EI-MS m/e (%): 246 (M{81Br}+, 93), 244 (M{79Br}+, 94), 165 ([M—Br]+, 100).']","[{'chemical_names': ['2,2-dicyano-1-methylsulfanyl-vinyl-cyanamide sodium salt'], 'identifiers': ['smiles:CSC(NC#N)=C(C#N)C#N.[Na]', 'inchi:InChI=1S/C6H4N4S.Na/c1-11-6(10-4-9)5(2-7)3-8;/h10H,1H3;'], 'amounts': ['5.37 mmol', '1.00 g'], 'appearances': []}, {'chemical_names': ['hydrobromic acid'], 'identifiers': ['smiles:Br', 'inchi:InChI=1S/BrH/h1H'], 'amounts': ['10 ml'], 'appearances': []}, {'chemical_names': ['ice water'], 'identifiers': [], 'amounts': ['100 ml'], 'appearances': []}]","[{'chemical_names': ['2-amino-4-bromo-6-methylsulfanyl-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:CSc1nc(N)nc(Br)c1C#N', 'inchi:InChI=1S/C6H5BrN4S/c1-12-5-3(2-8)4(7)10-6(9)11-5/h1H3,(H2,9,10,11)'], 'amounts': ['1.09 g', '83%'], 'appearances': ['white crystalline']}]","[{'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['10 ml'], 'appearances': []}]",[],"['step 1:To a stirred suspension of 1.00 g (5.37 mmol) 2,2-dicyano-1-methylsulfanyl-vinyl-cyanamide sodium salt in 10 ml acetic acid at 5° C.', 'step 1 properties:Temperature:5', 'step 2:was added dropwise 10 ml hydrobromic acid solution (33% in acetic acid)', 'step 3:the mixture was stirred at room temperature for 30 minutes', 'step 3 properties:Time:1800', 'step 3 properties:Temperature:room temperature', 'step 4:The mixture was then poured onto 100 ml ice-water', 'step 5:added', 'step 6:The resulting crystals were collected by filtration', 'step 7:washed with water (ca 500 ml) until the washings', 'step 8:Chromatography (ethyl acetate/hexane 1/4) afforded 1.09 g (83%) 2-amino-4-bromo-6-methylsulfanyl-pyrimidine-5-carbonitrile as a white crystalline solid']"
"['[NH2:1][C:2]1[N:7]=[C:6]([Cl:8])[C:5]([CH:9]=O)=[C:4]([Cl:11])[N:3]=1.C(O)(=O)C.Cl.[NH2:17][OH:18]', 'C(O)C', '[NH2:1][C:2]1[N:7]=[C:6]([Cl:8])[C:5]([CH:9]=[N:17][OH:18])=[C:4]([Cl:11])[N:3]=1 |f:2.3|']","['US20010027196A1', '1781', 'Following the method of Bell et al. (J. Heterocyclic Chem. 1983, 20, 41), to a solution of 29.6 g (154 mmol) 2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde in 31 acetic acid in a 2-necked flask at room temperature was added dropwise with stirring a solution of 11.8 g (170 mmol) hydroxylamine hydrochloride in 2.31 ethanol. Stirring was continued for 3 h at room temperature during which time crystallisation occurred. The crystals were collected by filtration to afford 26.8 g (84%) 2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde oxime as a light yellow crystalline solid. ES-MS m/e (%): 209 ([M{37Cl, 37Cl}-H]−, 20), 207 ([M{37Cl, 35Cl}-H]−, 55), 205 ([M{35Cl, 35Cl}-H]−, 100).']","[{'chemical_names': ['Heterocyclic'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde'], 'identifiers': ['smiles:Nc1nc(Cl)c(C=O)c(Cl)n1', 'inchi:InChI=1S/C5H3Cl2N3O/c6-3-2(1-11)4(7)10-5(8)9-3/h1H,(H2,8,9,10)'], 'amounts': ['154 mmol', '29.6 g'], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['hydroxylamine hydrochloride'], 'identifiers': ['smiles:Cl.NO', 'inchi:InChI=1S/ClH.H3NO/c;1-2/h1H;2H,1H2'], 'amounts': ['170 mmol', '11.8 g'], 'appearances': []}]","[{'chemical_names': ['2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde oxime'], 'identifiers': ['smiles:Nc1nc(Cl)c(C=NO)c(Cl)n1', 'inchi:InChI=1S/C5H4Cl2N4O/c6-3-2(1-9-12)4(7)11-5(8)10-3/h1,12H,(H2,8,10,11)'], 'amounts': ['26.8 g', '84%', '84.1'], 'appearances': ['light yellow crystalline']}]","[{'chemical_names': ['ethanol'], 'identifiers': ['smiles:CCO', 'inchi:InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:to a solution of 29.6 g (154 mmol) 2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde in 31 acetic acid in a 2-necked flask at room temperature was added dropwise', 'step 1 properties:Temperature:room temperature', 'step 2:with stirring a solution of 11.8 g (170 mmol) hydroxylamine hydrochloride in 2.31 ethanol', 'step 3:Stirring', 'step 4:was continued for 3 h at room temperature during which time crystallisation', 'step 4 properties:Time:10800', 'step 4 properties:Temperature:room temperature', 'step 5:The crystals were collected by filtration', 'step 6:to afford 26.8 g (84%) 2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde oxime as a light yellow crystalline solid']"
"['Cl.[NH2:2][C:3]1[N:8]=[C:7](Cl)[C:6]([CH:10]=[N:11]O)=[C:5]([Cl:13])[N:4]=1.C(O)(=[O:16])C', '', '[NH2:2][C:3]1[NH:8][C:7](=[O:16])[C:6]([C:10]#[N:11])=[C:5]([Cl:13])[N:4]=1']","['US20010027196A1', '1783', 'Following the method of Bell et al. (J. Heterocyclic Chem. 1983, 20, 41), hydrogen chloride gas was bubbled for 2 minutes though a solution of 6.00 g (29.0 mmol) 2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde oxime in 800 ml acetic acid at 115° C. The mixture was then stirred at 115° C. for 16 hours before being cooled to room temperature. The resulting crystals were removed by filtration, and the filtrate concentrated in vacuo. The residue was triturated in 100 ml ether to afford 4.60 g (93%) 2-amino-4-chloro-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile as a light yellow crystalline solid. EI-MS m/e (%): 172 (M{37Cl}+, 23), 170 (M{35Cl}+, 71), 129 (53), 43 (100).']","[{'chemical_names': ['Heterocyclic'], 'identifiers': [], 'amounts': [], 'appearances': []}, {'chemical_names': ['hydrogen chloride'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': [], 'appearances': []}, {'chemical_names': ['2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde oxime'], 'identifiers': ['smiles:Nc1nc(Cl)c(C=NO)c(Cl)n1', 'inchi:InChI=1S/C5H4Cl2N4O/c6-3-2(1-9-12)4(7)11-5(8)10-3/h1,12H,(H2,8,10,11)'], 'amounts': ['29.0 mmol', '6.00 g'], 'appearances': []}, {'chemical_names': ['acetic acid'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['800 ml'], 'appearances': []}]","[{'chemical_names': ['2-amino-4-chloro-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile'], 'identifiers': ['smiles:N#Cc1c(Cl)nc(N)[nH]c1=O', 'inchi:InChI=1S/C5H3ClN4O/c6-3-2(1-7)4(11)10-5(8)9-3/h(H3,8,9,10,11)'], 'amounts': ['4.60 g', '93%'], 'appearances': ['light yellow crystalline']}]",[],[],"['step 1:was bubbled for 2 minutes though a solution of 6.00 g (29.0 mmol) 2-amino-4,6-dichloro-pyrimidine-5-carbaldehyde oxime in 800 ml acetic acid at 115° C', 'step 1 properties:Time:120', 'step 1 properties:Temperature:115', 'step 2:The mixture was then stirred at 115° C. for 16 hours', 'step 2 properties:Time:57600', 'step 2 properties:Temperature:115', 'step 3:before being cooled to room temperature', 'step 3 properties:Temperature:room temperature', 'step 4:The resulting crystals were removed by filtration', 'step 5:the filtrate concentrated in vacuo', 'step 6:The residue was triturated in 100 ml ether', 'step 7:to afford 4.60 g (93%) 2-amino-4-chloro-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile as a light yellow crystalline solid']"
"['C(=O)([O-])[O-].[NH4+:5].[NH4+].[OH:7][C:8]1[CH:9]=[C:10]([C:17]([OH:19])=O)[C:11](=[CH:15][CH:16]=1)[C:12](O)=[O:13]', 'CC(O)=O', '[OH:7][C:8]1[CH:9]=[C:10]2[C:11](=[CH:15][CH:16]=1)[C:12](=[O:13])[NH:5][C:17]2=[O:19] |f:0.1.2|']","['US20010027202A1', '0085', 'To a mixture of ammonium carbonate (5.28 g, 54.9 mmol) in conc. AcOH (25 mL) was slowly added 4-hydroxyphthalic acid (5.0 g, 27.45 mmol). The resulting mixture was heated at 120° C. for 45 min., then the clear, bright yellow mixture was heated at 160° C. for 2 h. The resulting mixture was maintained at 160° C. and was concentrated to approximately 15 mL, then was cooled to room temp. and adjusted pH 10 with a 1N NaOH solution. This mixture was cooled to 0° C. and slowly acidified to pH 5 using a 1N HCl solution. The resultant precipitate was collected by filtration and dried under reduced pressure to yield 5-hydroxyisoindoline-1,3-dione as a pale yellow powder as product (3.24 g, 72%): 1H NMR (DMSO-d6) δ7.00-7.03 (m, 2H), 7.56 (d, J=9.3Hz, 1H).']","[{'chemical_names': ['ammonium carbonate'], 'identifiers': ['smiles:O=C([O-])[O-].[NH4+].[NH4+]', 'inchi:InChI=1S/CH2O3.2H3N/c2-1(3)4;;/h(H2,2,3,4);2*1H3'], 'amounts': ['54.9 mmol', '5.28 g'], 'appearances': []}, {'chemical_names': ['4-hydroxyphthalic acid'], 'identifiers': ['smiles:O=C(O)c1ccc(O)cc1C(=O)O', 'inchi:InChI=1S/C8H6O5/c9-4-1-2-5(7(10)11)6(3-4)8(12)13/h1-3,9H,(H,10,11)(H,12,13)'], 'amounts': ['27.45 mmol', '5.0 g'], 'appearances': []}]","[{'chemical_names': ['5-hydroxyisoindoline-1,3-dione'], 'identifiers': ['smiles:O=C1NC(=O)c2cc(O)ccc21', 'inchi:InChI=1S/C8H5NO3/c10-4-1-2-5-6(3-4)8(12)9-7(5)11/h1-3,10H,(H,9,11,12)'], 'amounts': [], 'appearances': ['pale yellow']}]","[{'chemical_names': ['AcOH'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['25 mL'], 'appearances': []}]",[],"['step 1:To a mixture of ammonium carbonate (5.28 g, 54.9 mmol) in conc. AcOH (25 mL)', 'step 2:The resulting mixture was heated at 120° C. for 45 min.', 'step 2 properties:Time:2700', 'step 2 properties:Temperature:120', 'step 3:the clear, bright yellow mixture was heated at 160° C. for 2 h', 'step 3 properties:Time:7200', 'step 3 properties:Temperature:160', 'step 4:The resulting mixture was maintained at 160° C.', 'step 4 properties:Temperature:160', 'step 5:was concentrated to approximately 15 mL', 'step 6:was cooled to room temp.', 'step 6 properties:Temperature:room temperature', 'step 7:This mixture was cooled to 0° C.', 'step 7 properties:Temperature:0', 'step 8:The resultant precipitate was collected by filtration', 'step 9:dried under reduced pressure', 'step 9 properties:Pressure:reduced pressure', 'step 10:to yield 5-hydroxyisoindoline-1,3-dione as a pale yellow powder as product (3.24 g, 72%)']"
"['[N+:1]([C:4]1[CH:21]=[CH:20][C:7]([O:8][C:9]2[CH:10]=[C:11]3[C:15](=[CH:16][CH:17]=2)[C:14](=[O:18])[NH:13][C:12]3=[O:19])=[CH:6][CH:5]=1)([O-])=O', 'CC(O)=O.O.[Fe]', '[NH2:1][C:4]1[CH:21]=[CH:20][C:7]([O:8][C:9]2[CH:10]=[C:11]3[C:15](=[CH:16][CH:17]=2)[C:14](=[O:18])[NH:13][C:12]3=[O:19])=[CH:6][CH:5]=1']","['US20010027202A1', '0089', 'A solution of 5-(4-nitrophenoxy)isoindoline-1,3-dione (0.6 g, 2.11 mmol) in conc. AcOH (12 mL) and water (0.1 mL) was stirred under stream of argon while iron powder (0.59 g, 55.9 mmol) was added slowly. This mixture stirred at room temp. for 72 h, then was diluted with water (25 mL) and extracted with EtOAc (3×50 mL). The combined organic layers were dried (MgSO4) and concentrated under reduced pressure to give 5-(4-aminophenoxy)isoindoline-1,3-dione as a brownish solid (0.4 g, 75%): TLC (50% EtOAc/50% hexane) Rf 0.27; 1H NMR (DMSO-d6) δ5.14 (br s, 2H), 6.62 (d, J=8.7 Hz, 2H), 6.84 (d, J=8.7 Hz, 2H), 7.03 (d, J=2.1 Hz, 1H), 7.23 (dd, 1H), 7.75 (d, J=8.4 Hz, 1H), 11.02 (s, 1H); HPLC ES-MS m/z 255 ((M+H)+, 100%).']","[{'chemical_names': ['5-(4-nitrophenoxy)isoindoline-1,3-dione'], 'identifiers': ['smiles:O=C1NC(=O)c2cc(Oc3ccc([N+](=O)[O-])cc3)ccc21', 'inchi:InChI=1S/C14H8N2O5/c17-13-11-6-5-10(7-12(11)14(18)15-13)21-9-3-1-8(2-4-9)16(19)20/h1-7H,(H,15,17,18)'], 'amounts': ['2.11 mmol', '0.6 g'], 'appearances': []}]","[{'chemical_names': ['5-(4-aminophenoxy)isoindoline-1,3-dione'], 'identifiers': ['smiles:Nc1ccc(Oc2ccc3c(c2)C(=O)NC3=O)cc1', 'inchi:InChI=1S/C14H10N2O3/c15-8-1-3-9(4-2-8)19-10-5-6-11-12(7-10)14(18)16-13(11)17/h1-7H,15H2,(H,16,17,18)'], 'amounts': ['0.4 g', '75%', '74.6'], 'appearances': ['brownish']}]","[{'chemical_names': ['AcOH'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['12 mL'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['0.1 mL'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['25 mL'], 'appearances': []}]","[{'chemical_names': ['iron'], 'identifiers': ['smiles:[Fe]', 'inchi:InChI=1S/Fe'], 'amounts': ['55.9 mmol', '0.59 g'], 'appearances': []}]","['step 1:A solution of 5-(4-nitrophenoxy)isoindoline-1,3-dione (0.6 g, 2.11 mmol) in conc. AcOH (12 mL) and water (0.1 mL) was stirred under stream of argon while iron powder (0.59 g, 55.9 mmol)', 'step 2:was added slowly', 'step 3:This mixture stirred at room temp. for 72 h', 'step 3 properties:Time:259200', 'step 3 properties:Temperature:room temperature', 'step 4:was diluted with water (25 mL)', 'step 5:extracted with EtOAc (3×50 mL)', 'step 6:The combined organic layers were dried (MgSO4)', 'step 7:concentrated under reduced pressure', 'step 7 properties:Pressure:reduced pressure', 'step 8:to give 5-(4-aminophenoxy)isoindoline-1,3-dione as a brownish solid (0.4 g, 75%)']"
"['[N+:1]([C:4]1[CH:10]=[C:9]([C:11]([CH3:14])([CH3:13])[CH3:12])[CH:8]=[CH:7][C:5]=1[NH2:6])([O-:3])=[O:2].CC(O)=O.[CH2:19]([CH2:23][C:24](=O)[CH3:25])[C:20]([CH3:22])=O', 'C1CCCCC1.C(Cl)Cl', '[C:11]([C:9]1[CH:8]=[CH:7][C:5]([N:6]2[C:24]([CH3:25])=[CH:23][CH:19]=[C:20]2[CH3:22])=[C:4]([N+:1]([O-:3])=[O:2])[CH:10]=1)([CH3:14])([CH3:13])[CH3:12]']","['US20010027202A1', '0092', 'To a stirring solution of 2-nitro-4-tert-butylaniline (0.5 g, 2.57 mmol) in cyclohexane (10 mL) was added AcOH (0.1 mL) and acetonylacetone (0.299 g, 2.63 mmol) via syringe. The reaction mixture was heated at 120° C. for 72 h with azeotropic removal of volatiles. The reaction mixture was cooled to room temp., diluted with CH2Cl2 (10 mL) and sequentially washed with a 1N HCl solution (15 mL), a 1N NaOH solution (15 mL) and a saturated NaCl solution (15 mL), dried (MgSO4) and concentrated under reduced pressure. The resulting orange-brown solids were purified via column chromatography (60 g SiO2; gradient from 6% EtOAc/94% hexane to 25% EtOAc/75% hexane) to give 1-(4-tert-butyl-2-nitrophenyl)-2,5-dimethylpyrrole as an orange-yellow solid (0.34 g, 49%): TLC (15% EtOAc/85% hexane) Rf 0.67; 1H NMR (CDCl3) d 1.34 (s, 9H), 1.89 (s, 6H), 5.84 (s, 2H), 7.19-7.24 (m, 1H), 7.62 (dd, 1H), 7.88 (d, J=2.4 Hz, 1H); CI-MS m/z 273 ((M+H)+, 50%).']","[{'chemical_names': ['2-nitro-4-tert-butylaniline'], 'identifiers': ['smiles:CC(C)(C)c1ccc(N)c([N+](=O)[O-])c1', 'inchi:InChI=1S/C10H14N2O2/c1-10(2,3)7-4-5-8(11)9(6-7)12(13)14/h4-6H,11H2,1-3H3'], 'amounts': ['2.57 mmol', '0.5 g'], 'appearances': []}, {'chemical_names': ['AcOH'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['0.1 mL'], 'appearances': []}, {'chemical_names': ['acetonylacetone'], 'identifiers': ['smiles:CC(=O)CCC(C)=O', 'inchi:InChI=1S/C6H10O2/c1-5(7)3-4-6(2)8/h3-4H2,1-2H3'], 'amounts': ['2.63 mmol', '0.299 g'], 'appearances': []}]","[{'chemical_names': ['1-(4-tert-butyl-2-nitrophenyl)-2,5-dimethylpyrrole'], 'identifiers': ['smiles:Cc1ccc(C)n1-c1ccc(C(C)(C)C)cc1[N+](=O)[O-]', 'inchi:InChI=1S/C16H20N2O2/c1-11-6-7-12(2)17(11)14-9-8-13(16(3,4)5)10-15(14)18(19)20/h6-10H,1-5H3'], 'amounts': ['0.34 g', '49%', '48.6'], 'appearances': ['orange-yellow']}]","[{'chemical_names': ['cyclohexane'], 'identifiers': ['smiles:C1CCCCC1', 'inchi:InChI=1S/C6H12/c1-2-4-6-5-3-1/h1-6H2'], 'amounts': ['10 mL'], 'appearances': []}, {'chemical_names': ['CH2Cl2'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': ['10 mL'], 'appearances': []}]",[],"['step 1:To a stirring solution of 2-nitro-4-tert-butylaniline (0.5 g, 2.57 mmol) in cyclohexane (10 mL) was added AcOH (0.1 mL) and acetonylacetone (0.299 g, 2.63 mmol) via syringe', 'step 2:The reaction mixture was heated at 120° C. for 72 h with azeotropic removal of volatiles', 'step 2 properties:Time:259200', 'step 2 properties:Temperature:120', 'step 3:The reaction mixture was cooled to room temp.', 'step 3 properties:Temperature:room temperature', 'step 4:diluted with CH2Cl2 (10 mL)', 'step 5:sequentially washed with a 1N HCl solution (15 mL)', 'step 6:a 1N NaOH solution (15 mL) and a saturated NaCl solution (15 mL), dried (MgSO4)', 'step 7:concentrated under reduced pressure', 'step 7 properties:Pressure:reduced pressure', 'step 8:The resulting orange-brown solids were purified via column chromatography (60 g SiO2; gradient from 6% EtOAc/94% hexane to 25% EtOAc/75% hexane)', 'step 9:to give 1-(4-tert-butyl-2-nitrophenyl)-2,5-dimethylpyrrole as an orange-yellow solid (0.34 g, 49%)']"
"['[OH:1][C:2]1[CH:12]=[C:6]2[C:7]([NH:9][C:10](=[O:11])[C:5]2=[CH:4][CH:3]=1)=O', 'CC(O)=O.[Zn]', '[OH:1][C:2]1[CH:12]=[C:6]2[C:5](=[CH:4][CH:3]=1)[C:10](=[O:11])[NH:9][CH2:7]2']","['US20010027202A1', '0129', 'To a solution of 5-hydroxyphthalimide (19.8 g, 121 mmol) in AcOH (500 mL) was slowly added zinc dust (47.6 g, 729 mmol) in portions, then the mixture was heated at the reflux temp. for 40 min., filtered hot, and concentrated under reduced pressure. The reaction was repeated on the same scale and the combined oily residue was purified by column chromatography (1.1 Kg SiO2; gradient from 60% EtOAc/40% hexane to 25% MeOH/75% EtOAc) to give 5-hydroxyisoindolin-1-one (3.77 g): TLC (100% EtOAc) Rf 0.17; HPLC ES-MS m/z 150 ((M+H)+).']","[{'chemical_names': ['5-hydroxyphthalimide'], 'identifiers': ['smiles:O=C1NC(=O)c2cc(O)ccc21', 'inchi:InChI=1S/C8H5NO3/c10-4-1-2-5-6(3-4)8(12)9-7(5)11/h1-3,10H,(H,9,11,12)'], 'amounts': ['121 mmol', '19.8 g'], 'appearances': []}]","[{'chemical_names': ['5-hydroxyisoindolin-1-one'], 'identifiers': ['smiles:O=C1NCc2cc(O)ccc21', 'inchi:InChI=1S/C8H7NO2/c10-6-1-2-7-5(3-6)4-9-8(7)11/h1-3,10H,4H2,(H,9,11)'], 'amounts': ['3.77 g', '20.9'], 'appearances': []}]","[{'chemical_names': ['AcOH'], 'identifiers': ['smiles:CC(=O)O', 'inchi:InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)'], 'amounts': ['500 mL'], 'appearances': []}]","[{'chemical_names': ['zinc'], 'identifiers': ['smiles:[Zn]', 'inchi:InChI=1S/Zn'], 'amounts': ['729 mmol', '47.6 g'], 'appearances': []}]","['step 1:the mixture was heated at the reflux temp', 'step 2:for 40 min.', 'step 2 properties:Time:2400', 'step 3:filtered hot', 'step 4:concentrated under reduced pressure', 'step 4 properties:Pressure:reduced pressure', 'step 5:the combined oily residue was purified by column chromatography (1.1 Kg SiO2; gradient from 60% EtOAc/40% hexane to 25% MeOH/75% EtOAc)', 'step 6:to give 5-hydroxyisoindolin-1-one (3.77 g)']"
